Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.

Thompson, Laura L; Jeusset, Lucile M-P; Lepage, Chloe C; McManus, Kirk J

Thompson, Laura L; Jeusset, Lucile M-P; Lepage, Chloe C; McManus, Kirk J.

Afiliación

Thompson LL; Department of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, MB R3T 2N2, Canada. laura.thompson@umanitoba.ca.
Jeusset LM; Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. laura.thompson@umanitoba.ca.
Lepage CC; Department of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, MB R3T 2N2, Canada. jeussetl@myumanitoba.ca.
McManus KJ; Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. jeussetl@myumanitoba.ca.

Cancers (Basel) ; 9(11)2017 Nov 01.

Article en En | MEDLINE | ID: mdl-29104272

Palabras clave

cancer; chromosome instability; combinatorial chemotherapy; intratumoral heterogeneity; precision medicine; synthetic lethality

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2017 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google